The etiology and pathogenesis of post-stroke depression patients are mainly caused by liver failure, spleen failure, kidney insufficiency, marrow loss and heart loss. Post-stroke depression patients suffer from chronic illness and multiple viscera of heart, liver, spleen and kidney, resulting in emotional disorders of patients. Acupuncture treatment with meridian acupoints can achieve the therapeutic purpose of regulating qi movement, resolving depression, calming heart and calming nerves. Acupoints selection for acupuncture treatment with meridian acupoints include Governor Vessel, stomach meridian, spleen meridian, gallbladder meridian and liver meridian. Needling in acupoints in Governor Vessel and yang meridians can regulate and replenish the middle qi, strengthen the brain and concentrate, and improve the depressed state of patients; needling in acupoints in liver meridian can soothe liver and resolve depression, regulate mood and emotion. The selected acupoints for acupuncture on the inner and outer meridians are the liver meridian-gallbladder meridian, spleen meridian-stomach meridian, and collateral accompanied acupoints. Needling at acupoints can promote and restore the movement of qi, exerting the power of regulating qi flow, relieving depression, and calming the mind. The acupoints selected for the acupuncture of the same named meridian are the acupoints of Jueyin meridians of the hands and feet. Needling related acupoints is used to soothe the liver, relieve depression, regulate the heart and calm the mind.

OBJECTIVE: To investigate the correlation between cyclin-dependent kinase inhibitor p27kip1 and trastuzumab-resistance in gastric cancer.
 METHODS: We selected HER2-overexpressed human gastric cancer cell line NCI-N87 to establish trastuzumab-resistant NCI-N87/TR cell line by stepwise exposure to different doses of trastuzumab. The 50% inhibitory concentration (IC(50)) of trastuzumab and resistance index (RI) were calculated or analyzed by MTT assay. The expression levels of cdk2 and p27kip1 were detected by Western blot. After the treatment with cdk2 inhibitor (Purvalanol A), the expression levels of relevant proteins in NCI-N87/TR cells were detected by Western blot, and the sensitivity to trastuzumab was analyzed by MTT assay. 
 RESULTS: Compared with NCI-N87 cells, the expression of cdk2 was significantly increased in NCI-N87/TR cells (P<0.001), while the expression of p27kip1 showed a significant decrease (P<0.001). Restoration of the p27kip1 protein expression by cdk2 inhibitor (Purvalanol A) increased the sensitivity of NCI-N87/TR to trastuzumab.
 CONCLUSION Down-regulation of p27kip1 might be a mechanism for triggering trastuzumab resistance to gastric cancer cell line NCI-N87.
Antineoplastic Agents ; pharmacology ; Cell Line, Tumor ; Cyclin-Dependent Kinase 2 ; antagonists & inhibitors ; genetics ; metabolism ; Cyclin-Dependent Kinase Inhibitor p27 ; genetics ; metabolism ; Drug Resistance, Neoplasm ; Humans ; Purines ; pharmacology ; Stomach Neoplasms ; genetics ; metabolism ; pathology ; Trastuzumab ; pharmacology